Notes
Slide Show
Outline
1
 
2

Outlines of presentation
  • Brief History of Sleep apnea
  • Epidemiology: From an exotic disease to a prevalent syndrome
  • Sleep apnea is associated with HT, what are the evidence?
  • Oxidative stress – the culprit of sleep apnea
  • Endothelial dysfunction, a prelude to CVD
  • Aborting the process
3
 
4
 
5
 
6
 
7
The first documented apneas
8
 
9
 
10
 
11
 
12
 
13
 
14
 
15
 
16

Outlines of presentation
  • Epidemiology: From an exotic disease to a prevalent syndrome
  • Sleep apnea is associated with HT, what are the evidence?
  • Oxidative stress – the culprit of sleep apnea
  • Endothelial dysfunction, a prelude to CVD
  • Aborting the process
17
 
18
 
19
 
20
 
21
Young’s et al NEJM study
22
 
23

Outlines of presentation
  • Epidemiology: From an exotic disease to a prevalent syndrome
  • Sleep apnea is associated with HT, what are the evidence?
  • Oxidative stress – the culprit of sleep apnea
  • Endothelial dysfunction, a prelude to CVD
  • Aborting the process
24
 
25
 
26
 
27
 
28
Total number of subjects 11,157
  • Feb/00         Lavie, Herer and Hoffstein, BMJ.
  •                                             Sleep lab population, 2677 patients,
  •                                             OR AHI=30 vs. AHI<10 ~1.33
  • April/00          Nieto et al, JAMA
  •                                             Sleep-Heart Health Study, 6132
  •                                             subjects, AHI>30 vs.<1.5 OR=1.37
  • May/00            Peppard et al, N Engl J Med
  •                                             Wisconsin Sleep Study, prospective,
  •                                             709 subjects followed for 4 yrs, OR
  •                                             AHI>15 vs. 0=2.89
  •  Aug/00        Bixler et al, Arch Intern Med. 1741 subjects, SDB
  •                                             independently associated with HT, strongest in young
  • June/00          Grote, Hedner and Peter, J. Hypertension, 599
  •                                                patients, RDI independent predictor in pat <50 y
29
 
30
 
31
 
32
 
33
 
34
 
35
More supporting evidence
  • Prospective studies
  •    Peppered et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000
  • Treatment effects
  •    Pepperell et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomized parallel trial.
    Lancet. 2002
  • Animal model
  •    Brooks et al. Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model.
    J. Clin Invest 1997.
36
 
37
 
38
 
39
 
40

Outlines of presentation
  • Epidemiology: From an exotic disease to a prevalent syndrome
  • Sleep apnea is associated with CVD, what are the evidence?
  • Oxidative stress – the culprit of sleep apnea
  • Endothelial dysfunction, a prelude to CVD
  • Aborting the process
41
 
42
 
43
 
44
Increased Oxidative stress
in OSA
  • Production of free radicals  from Monocytes, lymphocytes and granulocytes
  • Pro-inflammatory cytokines
  • Anti-inflammatory cytokines
  • Adhesion molecules
  • Oxidized plasma Lipids
  • Diminished antioxidants capacity (Decreased PON1, increased 2-2 Hp phenotype)


45
              Basal and PMA DHE oxidation in controls and OSA patients matched by age sex and BMI
46
Basal and PMA DHE oxidation in controls and OSA patients matched by age sex and BMI
47
Basal and PMA DHE oxidation in controls and OSA patients matched by age sex and BMI
48
Increased Oxidative stress
in OSA
  • Production of free radicals  from Monocytes, lymphocytes and granulocytes
  • Pro-inflammatory cytokines
  • Anti-inflammatory cytokines
  • Adhesion molecules
  • Oxidized plasma Lipids
  • Diminished antioxidants capacity (Decreased PON1, increased 2-2 Hp phenotype)


49
 
50
TBARS and Peroxides concentrations               in OSA patients with and without CAD
51
PON1 activity in OSA
adjusted for age, BMI, hypercholesterolemia, creatinine and glucose
52
Oxidative stress in Sleep Apnea
53
 
54
 
55

Outlines of presentation
  • Epidemiology: From an exotic disease to a prevalent syndrome
  • Sleep apnea is associated with CVD, what are the evidence?
  • Oxidative stress – the culprit of sleep apnea
  • Endothelial dysfunction, a prelude to CVD
  • Aborting the process
56
"shear stress and changes in..."


  • shear stress and changes in hydrostatic pressure are sensed by the endothelium and stimulate nitric oxide release resulting in reactive hyperemia and vasodilation
57
 
58
 
59
PAT-Reactive Hyperemia Protocol
60
 
61
 
62
 
63
 
64
 
65
Early signs of atherosclerosis in sleep apnea
  • Increased intima-media thickness
  •      Drager et al, 2005
  • Arterial plaque formation
  •     Kaynak et al, 2003
  • Calcified artery atheromas
  •     Friedlander et al, 1999
  • Atherosclerotic lesions
  •     Aboyans et al, 1999
  • Higher pulse wave velocity
  •     Drager et al, 2005
66
 
67
Progression from ED to CVD (2)
68

Outlines of presentation
  • Epidemiology: From an exotic disease to a prevalent syndrome
  • Sleep apnea is associated with CVD, what are the evidence?
  • Oxidative stress – the culprit of sleep apnea
  • Endothelial dysfunction, a prelude to CVD
  • Aborting the process
69
 
70
Mean EF significantly improved following 3 months CPAP treatment
71
 
72
 
73
 
74
Population
  • 14,984 male adult patients studied in the Technion Sleep Medicine Center during a 9-year period (January 1st, 1991- October 1st , 2000) because of suspected OSA


  • Examination age: 48.4±12.3 yrs
  • Prior to September 1st, 2001, 2.6% (481) of the men died


  • Death age: 62.4±12.1
  • Follow-up period: 4.8 years
75
 
76